Cerenome secures up to $20 million senior secured facility from 3i Fund with royalty-based repayment
CNSY•Senior secured financing and repayment structure
Cerenome entered a senior secured financing agreement with 3i Fund for a facility of up to USD 20 million.
- Initial tranche funded at closing; additional tranches become available upon achievement of specified milestones.
- Repayments are structured as royalties, aiming to limit shareholder dilution.
- Proceeds target commercial scale-up of the CNSide cerebrospinal fluid assay platform.
- Cash runway forecast extends into 2028, factoring in the 3i facility, existing facilities, cash, sales, and cash flow.
